Vaxfab Enterprises posts ₹363.80 lakh FY26 profit, schedules AGM
- Standalone PAT surged to ₹363.80 lakh in FY26 from ₹33.72 lakh in FY25
- Revenue from operations grew 60.4% YoY to ₹9,410.75 lakh
- Authorized share capital increased to ₹50 crore ahead of AGM
- Consolidated net loss widened to ₹4,630.84 lakh due to group-level expenses
- 43rd AGM scheduled for September 29, 2026, in Ahmedabad

*this image is generated using AI for illustrative purposes only.
Vaxfab Enterprises reported a standalone profit after tax (PAT) of ₹363.80 lakh for the financial year ended March 31, 2026, a significant increase from ₹33.72 lakh in the previous year. The board approved a rise in authorized share capital to ₹50 crore and scheduled the 43rd annual general meeting for September 29, 2026.
The meeting will focus on corporate governance updates, including the reappointment of Managing Director Ravindra Ashokbhai Joshi and the appointment of M/s. Chandabhoy & Jassoobhoy as statutory auditors.
Financial Performance
Standalone revenue from operations grew to ₹9,410.75 lakh in FY26, compared to ₹5,867.10 lakh in FY25. Total revenue stood at ₹9,959.59 lakh, driven by other income of ₹548.84 lakh, which rose sharply from ₹70.56 lakh in the prior year.
| Metric | FY26 | FY25 | Change |
|---|---|---|---|
| Revenue from Operations | ₹9,410.75 lakh | ₹5,867.10 lakh | +60.4% |
| Profit Before Tax | ₹517.47 lakh | ₹45.65 lakh | +1,033.6% |
| Profit After Tax | ₹363.80 lakh | ₹33.72 lakh | +978.6% |
Consolidated figures showed a net loss of ₹4,630.84 lakh for FY26, contrasting with a profit of ₹33.72 lakh in FY25. Consolidated revenue from operations was ₹13,126.91 lakh.
Capital Structure Adjustment
The company increased its authorized share capital by ₹15 crore. The revised structure details are as follows:
| Share Type | Previous Authorized | New Authorized | Face Value |
|---|---|---|---|
| Equity Shares | 3.47 crore units | 4.97 crore units | ₹10 each |
| Preference Shares | 3 lakh units | 3 lakh units | ₹10 each |
| Total Capital | ₹35 crore | ₹50 crore | - |
The number of preference shares remains unchanged at 3 lakh units. The entire increase in authorized capital comes from the equity share component, adding 1.5 crore potential equity shares to the company's ceiling.
Annual General Meeting Details
The board scheduled the 43rd annual general meeting for Tuesday, September 29, 2026, at 12:00 pm. The meeting will be held at the registered office in Ahmedabad, Gujarat.
Key logistical details include:
- Remote e-voting facility available from September 26, 2026, at 9:00 am to September 28, 2026, at 5:00 pm.
- Cut-off date for voting eligibility is September 22, 2026.
- Mrs. Shubhangi Rajkumar Agarwal appointed as scrutinizer for the venue voting process.
Members holding shares in dematerialized form as on the cut-off date may cast votes through the remote e-voting system or via ballot paper at the AGM.
Historical Stock Returns for Vaxfab Enterprises
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.69% | -6.91% | +9.35% | +58.98% | +121.11% | 0.0% |
What strategic initiatives or operational changes drove the 60.4% surge in standalone revenue from operations in FY26?
How does the company plan to address the significant divergence between its profitable standalone results and the consolidated net loss of ₹46.3 crore?
Does the increase in authorized share capital signal an impending equity fundraising round or strategic partnership, and what are the intended uses for these new shares?


































